SCHEMBL7080816

SCHEMBL7080816

Nc1nc(P(=O)(O)OP(=O)(O)O)nc2nc[nH]c12

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PDPK1 O15530 1/20 0.49
▸ GDA Q9Y2T3 1/20 0.49
▸ KDR P35968 1/20 0.40
▸ AURKB Q96GD4 1/20 0.40
▸ DPP4 P27487 1/20 0.40
▸ PI4KA P42356 2/20 0.39
▸ PI4K2B Q8TCG2 2/20 0.39
▸ PI4K2A Q9BTU6 2/20 0.39
▸ PI4KB Q9UBF8 2/20 0.39
▸ LMNA P02545 1/20 0.39
▸ DRD3 P35462 1/20 0.39
▸ XDH P47989 1/20 0.39
▸ LRRK2 Q5S007 1/20 0.39
▸ PNP P00491 1/20 0.39
▸ MGMT P16455 4/20 0.37
▸ CDK2 P24941 5/20 0.36
▸ CDK1 P06493 4/20 0.36
▸ CCNB1 P14635 4/20 0.36
▸ CCNA2 P20248 4/20 0.36
▸ CCNA1 P78396 4/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2698567 0.83 PDPK1 (0.56) PDPK1GDAKDRAURKBDPP4
SCHEMBL27586020 0.83 PDPK1 (0.56) PDPK1GDAKDRAURKBDPP4
Triphosphate SCHEMBL1074476 0.80 PDPK1 (0.66) PDPK1GDAKDRAURKBDPP4
Sulfuric Acid SCHEMBL31515565 0.78 PDPK1 (0.50) PDPK1GDAKDRAURKBDPP4
Triphosphate SCHEMBL30196670 0.78 PDPK1 (0.46) PDPK1GDAKDRAURKBDPP4
Adenine SCHEMBL27565227 0.76 PI4KA (0.61) PDPK1GDAKDRAURKBDPP4
2,6-Diaminopurine SCHEMBL13857840 0.75 PDPK1 (0.79) PDPK1GDADPP4PI4KAPI4K2B
Adenine SCHEMBL1035725 0.75 PI4KA (0.69) PDPK1GDAPI4KAPI4K2BPI4K2A
Triphosphate SCHEMBL27978070 0.73 ADORA3 (0.51) PDPK1GDAKDRAURKBLMNA
Triphosphate SCHEMBL502620 0.72 PI4KA (0.65) PDPK1GDAPI4KAPI4K2BPI4K2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2003068167-A2 NOVEL TREATMENT FOR PATHOLOGIES ASSOCIATED WITH OXIDATIVE DAMAGE THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2003-08-21 — — WO disclosed
US-20020156585-A1 Crystallization and structure determination of Staphylococcus aureus UDP-N-acetylenolpyruvylglucosamine reductase (S. aureus MurB) PHARMACIA & UPJOHN COMPANY 2002-10-24 — — US disclosed
WO-2001011054-A9 CRYSTALLIZATION AND STRUCTURE DETERMINATION OF STAPHYLOCOCCUS AUREUS UDP-N-ACETYLENOLPYRUVYLGLUCOSAMINE REDUCTASE (S. AUREUS MurB) UPJOHN CO (US) 2002-09-26 — — WO disclosed
EP-1200599-A1 CRYSTALLIZATION AND STRUCTURE DETERMINATION OF STPHYLOCOCCUS AUREUS UDP-N-ACETYLENOLPYRUVYLGLUCOSAMINE REDUCTASE (S. AUREUS MurB) PHARMACIA & UPJOHN COMPANY (US) 2002-05-02 — — EP disclosed
US-6356845-B1 Crystallization and structure determination of Staphylococcus aureus UDP-N-acetylenolpyruvylglucosamine reductase (S. aureus MurB) PHARMACIA & UPJOHN COMPANY 2002-03-12 — — US disclosed
WO-2001011054-A1 CRYSTALLIZATION AND STRUCTURE DETERMINATION OF STAPHYLOCOCCUS AUREUS UDP-N-ACETYLENOLPYRUVYLGLUCOSAMINE REDUCTASE (S. AUREUS MurB) PHARMACIA & UPJOHN COMPANY (US) 2001-02-15 — — WO disclosed
Send feedback